266 related articles for article (PubMed ID: 22864741)
1. Effect of particle size on the dissolution behaviors of poorly water-soluble drugs.
Chu KR; Lee E; Jeong SH; Park ES
Arch Pharm Res; 2012 Jul; 35(7):1187-95. PubMed ID: 22864741
[TBL] [Abstract][Full Text] [Related]
2. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
3. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
4. Miniaturization of powder dissolution measurement and estimation of particle size.
Avdeef A; Tsinman K; Tsinman O; Sun N; Voloboy D
Chem Biodivers; 2009 Nov; 6(11):1796-811. PubMed ID: 19937817
[TBL] [Abstract][Full Text] [Related]
5. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
Kumar D; Sailaja Chirravuri SV; Shastri NR
Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106
[TBL] [Abstract][Full Text] [Related]
6. Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs.
Overhoff KA; Engstrom JD; Chen B; Scherzer BD; Milner TE; Johnston KP; Williams RO
Eur J Pharm Biopharm; 2007 Jan; 65(1):57-67. PubMed ID: 16987642
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous micronization and surface modification for improvement of flow and dissolution of drug particles.
Han X; Ghoroi C; To D; Chen Y; Davé R
Int J Pharm; 2011 Aug; 415(1-2):185-95. PubMed ID: 21664954
[TBL] [Abstract][Full Text] [Related]
8. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
Tay T; Allahham A; Morton DA; Stewart PJ
Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
[TBL] [Abstract][Full Text] [Related]
9. Physical state and dissolution of ibuprofen formulated by co-spray drying with mesoporous silica: effect of pore and particle size.
Shen SC; Ng WK; Chia L; Hu J; Tan RB
Int J Pharm; 2011 May; 410(1-2):188-95. PubMed ID: 21419202
[TBL] [Abstract][Full Text] [Related]
10. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
De Zordi N; Moneghini M; Kikic I; Grassi M; Del Rio Castillo AE; Solinas D; Bolger MB
Eur J Pharm Biopharm; 2012 May; 81(1):131-41. PubMed ID: 22266263
[TBL] [Abstract][Full Text] [Related]
11. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
12. Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process.
Paulino AS; Rauber G; Campos CE; Maurício MH; de Avillez RR; Capobianco G; Cardoso SG; Cuffini SL
Eur J Pharm Sci; 2013 May; 49(2):294-301. PubMed ID: 23557843
[TBL] [Abstract][Full Text] [Related]
13. A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2010 Feb; 386(1-2):256-61. PubMed ID: 19922777
[TBL] [Abstract][Full Text] [Related]
14. Understanding improved dissolution of indomethacin through the use of cohesive poorly water-soluble aluminium hydroxide: effects of concentration and particle size distribution.
Tay T; Allahham A; Morton DA; Stewart PJ
J Pharm Sci; 2011 Oct; 100(10):4269-80. PubMed ID: 21560127
[TBL] [Abstract][Full Text] [Related]
15. In situ controlled crystallization as a tool to improve the dissolution of Glibenclamide.
Elkordy AA; Jatto A; Essa E
Int J Pharm; 2012 May; 428(1-2):118-20. PubMed ID: 22426322
[TBL] [Abstract][Full Text] [Related]
16. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
17. Dissolution characteristics of cylindrical particles and tablets.
Fukunaka T; Yaegashi Y; Nunoko T; Ito R; Golman B; Shinohara K
Int J Pharm; 2006 Mar; 310(1-2):146-53. PubMed ID: 16414218
[TBL] [Abstract][Full Text] [Related]
18. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
19. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
